Histological Analysis of Bellafill Injected Tissue at Various Time Points
Histological Analysis of Bellafill Injected Tissue at Various Time Points: A Proof of Concept Study
Sponsor: Suneva Medical, Inc.
Listed as NCT03327311, this observational or N/A phase trial focuses on Histopathology and remains completed. Sponsored by Suneva Medical, Inc., it has been updated 9 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
▶ Show 4 earlier versions
-
Jun 2018 — Nov 2020 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Nov 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Aug 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Suneva Medical, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .